Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Citadel Group M&A Activity 2020

Apr 29, 2020

10454_mrq_2020-04-29_40b47506-2b2a-4ee2-93c9-5f3365b6dbcc.html

M&A Activity

Open in viewer

Opens in your device viewer

National Storage Mechanism | Additional information

RNS Number : 3454L

Citadel Group

29 April 2020

Ap 19

FORM 8.3

IRISH TAKEOVER PANEL

DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

1.         KEY INFORMATION

Name of person dealing (Note 1)

Citadel Group

Company dealt in

ALLERGAN PLC

Class of relevant security to which the dealings being disclosed relate (Note 2)

Common Stock ISIN IE00BY9D5467

Date of dealing

28 April, 2020

2.         INTERESTS AND SHORT POSITIONS

(a)        Interests and short positions (following dealing) in the class of relevant security

dealt in (Note 3)

Long Short
Common Stock  ISIN  IE00BY9D5467 Number        (%) Number      (%)
(1) Relevant securities 3,133,451 (0.95%) 30 (0.00%)
(2) Derivatives (other than options) 3,465,201 (1.05%) 0 (0.00%)
(3) Options and agreements to purchase/sell 0 (0.00%) 0 (0.00%)
Total 6,598,652(2.01%) 30 (0.00%)

(b)        Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)

Long Short
Number        (%) Number      (%)
(1) Relevant securities
(2) Derivatives (other than options)
(3) Options and agreements to purchase/sell
Total

Ap 20

1.         DEALINGS (Note 4)

(a)        Purchases and sales

Purchase/sale

Common Stock ISIN IE00BY9D5467
Number of securities Price per unit (Note 5)
Purchase 400 187.03  USD
Purchase 200 187.04  USD
Purchase 220 187.10954545  USD
Purchase 200 187.13  USD
Purchase 67 187.28  USD
Purchase 2,005 187.29630424  USD
Purchase 70 187.302  USD
Purchase 58 187.32551724  USD
Purchase 2,812 187.35  USD
Purchase 1,498 187.35220294  USD
Purchase 825 187.38033939  USD
Purchase 1,737 187.38601612  USD
Purchase 560 187.4025  USD
Purchase 326 187.43944785  USD
Purchase 443 187.47611738  USD
Purchase 100 187.51  USD
Purchase 1,148 187.54651568  USD
Purchase 770 187.59694156  USD
Purchase 2 187.64  USD
Purchase 800 187.651875  USD
Purchase 300 187.67333333  USD
Purchase 6 187.72  USD
Purchase 200 187.79  USD
Sale -267 187.34715356  USD
Sale -266 187.34834586  USD
Sale -100 187.38  USD
Sale -341 187.39709677  USD
Sale -234 187.39777778  USD
Sale -788 187.40756345  USD
Sale -108 187.48203704  USD
Sale -12,271 187.497413  USD
Sale -1,507 187.50731254  USD
Sale -1,430 187.511  USD
Sale -450 187.51577778  USD
Sale -262 187.52045802  USD
Sale -17,729 187.625931  USD
Sale -449 187.63218263  USD
Sale -126 187.64857143  USD
Sale -2,005 187.65785037  USD
Sale -527 187.65804554  USD
Sale -100 187.7  USD
Sale -558 187.7097491  USD
Sale -2,036 187.7861002  USD
Sale -10 187.83  USD
Sale -496 187.84096774  USD
Sale -6 187.89  USD
Sale -125 187.9256  USD
Sale -200 188.145  USD
Sale -518 188.27027027  USD
Sale -50 188.4  USD
Sale -23 188.51826087  USD

(b)        Derivatives transactions (other than options transactions)

Product name,

e.g. CFD

 ISIN
Nature of transaction

(Note 6)
Number of relevant securities

(Note 7)
Price per unit

(Note 5)

(c)        Options transactions in respect of existing relevant securities

(i)         Writing, selling, purchasing or varying

Product name, e.g. call option Writing, selling, purchasing,

varying etc.
Number of securities to which the option relates (Note 7) Exercise price Type,

e.g. American, European etc.
Expiry date Option money paid/ received per unit

(Note 5)

(ii)        Exercising

Product name,

e.g. call option
Number of securities Exercise price per unit

(Note 5)

(d)        Other dealings (including transactions in respect of new securities) (Note 4)

Nature of transaction

(Note 8)
Details Price per unit

      (if applicable) (Note 5)

Ap 21

2.         OTHER INFORMATION

Agreements, arrangements or understandings relating to options or derivatives

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated
None

Is a Supplemental Form 8 attached? (Note 9)

NO

Date of disclosure: 29 April, 2020
Contact name: Katie Bonds
Telephone number: 020 7645 9700
If a connected EFM, name of offeree/offeror with which connected n/a
If a connected EFM, state nature of connection (Note 10) n/a

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

END

ISEBBGDSRGDDGGC